Literature DB >> 16987985

Crystal structure of the West Nile virus envelope glycoprotein.

Grant E Nybakken1, Christopher A Nelson, Beverly R Chen, Michael S Diamond, Daved H Fremont.   

Abstract

The envelope glycoprotein (E) of West Nile virus (WNV) undergoes a conformational rearrangement triggered by low pH that results in a class II fusion event required for viral entry. Herein we present the 3.0-A crystal structure of the ectodomain of WNV E, which reveals insights into the flavivirus life cycle. We found that WNV E adopts a three-domain architecture that is shared by the E proteins from dengue and tick-borne encephalitis viruses and forms a rod-shaped configuration similar to that observed in immature flavivirus particles. Interestingly, the single N-linked glycosylation site on WNV E is displaced by a novel alpha-helix, which could potentially alter lectin-mediated attachment. The localization of histidines within the hinge regions of E implicates these residues in pH-induced conformational transitions. Most strikingly, the WNV E ectodomain crystallized as a monomer, in contrast to other flavivirus E proteins, which have crystallized as antiparallel dimers. WNV E assembles in a crystalline lattice of perpendicular molecules, with the fusion loop of one E protein buried in a hydrophobic pocket at the DI-DIII interface of another. Dimeric E proteins pack their fusion loops into analogous pockets at the dimer interface. We speculate that E proteins could pivot around the fusion loop-pocket junction, allowing virion conformational transitions while minimizing fusion loop exposure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987985      PMCID: PMC1642602          DOI: 10.1128/JVI.01125-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Structure of West Nile virus.

Authors:  Suchetana Mukhopadhyay; Bong-Suk Kim; Paul R Chipman; Michael G Rossmann; Richard J Kuhn
Journal:  Science       Date:  2003-10-10       Impact factor: 47.728

2.  West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness.

Authors:  T J Chambers; M Halevy; A Nestorowicz; C M Rice; S Lustig
Journal:  J Gen Virol       Date:  1998-10       Impact factor: 3.891

3.  Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus.

Authors:  Alain Roussel; Julien Lescar; Marie-Christine Vaney; Gisela Wengler; Gerd Wengler; Félix A Rey
Journal:  Structure       Date:  2006-01       Impact factor: 5.006

4.  Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus.

Authors:  Kazuya Shirato; Hirotsugu Miyoshi; Akiko Goto; Yoshihiko Ako; Tomotaka Ueki; Hiroaki Kariwa; Ikuo Takashima
Journal:  J Gen Virol       Date:  2004-12       Impact factor: 3.891

5.  N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity.

Authors:  Sheri L Hanna; Theodore C Pierson; Melissa D Sanchez; Asim A Ahmed; Mariam M Murtadha; Robert W Doms
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 6.  West Nile virus: where are we now?

Authors:  Bruno P Granwehr; Kristy M Lillibridge; Stephen Higgs; Peter W Mason; Judith F Aronson; Gerald A Campbell; Alan D T Barrett
Journal:  Lancet Infect Dis       Date:  2004-09       Impact factor: 25.071

7.  Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN.

Authors:  Elena Pokidysheva; Ying Zhang; Anthony J Battisti; Carol M Bator-Kelly; Paul R Chipman; Chuan Xiao; G Glenn Gregorio; Wayne A Hendrickson; Richard J Kuhn; Michael G Rossmann
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

8.  Conditions for haemolysis by flaviviruses and characterization of the haemolysin.

Authors:  N Cammack; E A Gould
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

9.  Genome sequence and attenuating mutations in West Nile virus isolate from Mexico.

Authors:  David W C Beasley; C Todd Davis; Jose Estrada-Franco; Roberto Navarro-Lopez; Arturo Campomanes-Cortes; Robert B Tesh; Scott C Weaver; Alan D T Barrett
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

10.  Structural basis of West Nile virus neutralization by a therapeutic antibody.

Authors:  Grant E Nybakken; Theodore Oliphant; Syd Johnson; Stephen Burke; Michael S Diamond; Daved H Fremont
Journal:  Nature       Date:  2005-09-29       Impact factor: 49.962

View more
  130 in total

1.  Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.

Authors:  Juergen Zlatkovic; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

Review 2.  Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors:  Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal:  Virol Sin       Date:  2015-10-20       Impact factor: 4.327

3.  Location and role of free cysteinyl residues in the Sindbis virus E1 and E2 glycoproteins.

Authors:  Christopher B Whitehurst; Erik J Soderblom; Michelle L West; Raquel Hernandez; Michael B Goshe; Dennis T Brown
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

4.  Structure of immature West Nile virus.

Authors:  Ying Zhang; Bärbel Kaufmann; Paul R Chipman; Richard J Kuhn; Michael G Rossmann
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Solution structure of the envelope protein domain III of dengue-4 virus.

Authors:  David E Volk; Yi-Chien Lee; Xin Li; Varatharasa Thiviyanathan; Gregory D Gromowski; Li Li; Ashley R Lamb; David W C Beasley; Alan D T Barrett; David G Gorenstein
Journal:  Virology       Date:  2007-03-29       Impact factor: 3.616

6.  A small-molecule dengue virus entry inhibitor.

Authors:  Qing-Yin Wang; Sejal J Patel; Eric Vangrevelinghe; Hao Ying Xu; Ranga Rao; Deana Jaber; Wouter Schul; Feng Gu; Olivier Heudi; Ngai Ling Ma; Mee Kian Poh; Wai Yee Phong; Thomas H Keller; Edgar Jacoby; Subhash G Vasudevan
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

7.  Identification of novel target sites and an inhibitor of the dengue virus E protein.

Authors:  Ragothaman Yennamalli; Naidu Subbarao; Thorsten Kampmann; Ross P McGeary; Paul R Young; Bostjan Kobe
Journal:  J Comput Aided Mol Des       Date:  2009-02-25       Impact factor: 3.686

8.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  Protonation of individual histidine residues is not required for the pH-dependent entry of west nile virus: evaluation of the "histidine switch" hypothesis.

Authors:  Steevenson Nelson; Subhajit Poddar; Tsai-Yu Lin; Theodore C Pierson
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

10.  A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.

Authors:  Nathalie Bonafé; Joseph A Rininger; Richard G Chubet; Harald G Foellmer; Stacey Fader; John F Anderson; Sandra L Bushmich; Karen Anthony; Michel Ledizet; Erol Fikrig; Raymond A Koski; Paul Kaplan
Journal:  Vaccine       Date:  2008-11-07       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.